#United States #healthcare #Amgen #Thousand Oaks #Conference

Amgen's Presentation at Jefferies Global Healthcare Conference

Amgen Inc. is gearing up to participate in the prestigious Jefferies Global Healthcare Conference scheduled for June 4, 2026. The event takes place at 9:55 a.m. ET, and is expected to draw significant attention from industry experts, investors, and the media.

Key executives from Amgen, including Peter Griffith, Executive Vice President and Chief Financial Officer, Narimon Honarpour, Senior Vice President of Global Development, and Kave Niksefat, Senior Vice President of Global Marketing and Access, will be leading the discussions. The trio will present insights into the future initiatives of the company, announcing what's next for their innovative pipeline.

The presentation will be accessible through a live webcast, designed to cater to not just the media but also investors and the general public. This aligns with Amgen's commitment to transparency and public engagement. Interested parties can find all relevant information regarding the presentation and access links on the Amgen Investor Relations Events Calendar. After the event, the presentation will be archived, allowing viewers to access it for at least 90 days.

About Amgen

Amgen has established itself as a leader in the biotechnology sector, with a robust history of discovery and innovation. Founded over 45 years ago in Thousand Oaks, California, the company has been at the forefront of producing transformative therapies for some of the most challenging diseases. Utilizing cutting-edge technology and the latest in biological research, Amgen delivers vital medications that enhance the quality of life for millions worldwide.

The company boasts a diverse and deep pipeline targeting several medical conditions, including cancer, inflammatory diseases, rare disorders, heart disease, and obesity. Amgen's innovation has not gone unnoticed; they consistently receive accolades for their workplace culture and technological advancements, with recognitions from esteemed publications such as Forbes and Fast Company. Additionally, Amgen is a member of the Dow Jones Industrial Average and features in the Nasdaq-100 Index, spotlighting its status among the most innovative non-financial firms.

For more comprehensive updates and insights about their ongoing projects, Amgen encourages stakeholders to visit their official website and follow them across various social media platforms including X (formerly Twitter), LinkedIn, Instagram, YouTube, Facebook, TikTok, and Threads.

Conclusion

Amgen's upcoming presentation at the Jefferies Global Healthcare Conference promises to be a pivotal moment, showcasing the company's dedication to advancing healthcare through innovation. As the world looks forward to the revelations that this presentation will bring, the emphasis on accessibility for all audiences underscores Amgen's commitment to community welfare and health advancement. Whether you are an investor, a media representative, or a healthcare enthusiast, this event will provide valuable insights into the future of biotechnology and its impact on global health.

For media inquiries, Elissa Snook can be contacted at 609-251-1407, while investor-related questions should be directed to Casey Capparelli at 805-447-1746.